Introduction {#sec1}
============

Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that persistently infects the majority of the world's population ([@bib23]). Following primary infection, HCMV persists for the lifetime of the host under the control of a healthy immune system ([@bib24]). Reactivation from viral latency to productive infection in immunocompromised individuals, and acquisition of primary infection in utero or during transplantation can lead to serious disease ([@bib23]). With the possibility of CMV being used as a vaccine vector ([@bib12]), a complete understanding of its ability to modulate host immunity is paramount.

During productive infection, HCMV gene expression is conventionally divided into immediate-early (IE), early (E), and late (L) phases. The *IE2* gene is primarily responsible for activating transcription of early-phase genes. By definition, early genes encode functions necessary to initiate viral DNA replication. Early-late genes (E-L) are initially transcribed at low levels and upregulated after the onset of viral DNA replication, whereas true-late genes are expressed exclusively after DNA replication and include proteins required for the assembly and morphogenesis of HCMV virions ([@bib23]).

HCMV is a paradigm for viral immune evasion that perturbs the interferon (IFN) response ([@bib29]), suppresses antigen presentation through the efficient downregulation of MHC class I ([@bib43]), and has eight or more genes that act to suppress natural killer (NK) cell function ([@bib49]). Nevertheless, our understanding of how HCMV evades and modulates intrinsic immune sensors and effectors during infection remains superficial. It is not known which viral proteins are present at the cell surface, or how viral and host proteins are regulated during infection. Prior analysis of the temporal expression of HCMV genes has relied either on semiquantitative immunoblots of single viral proteins, or microarrays, which cannot capture posttranscriptional change ([@bib21]). Although 604 noncanonical HCMV open reading frames (ORFs) have been identified by ribosomal footprinting ([@bib36]), it is not yet clear how many of these ORFs encode functional polypeptides. Answering such questions has the potential to reveal mechanisms of immune evasion, cell-surface drug targets, and an improved understanding of HCMV biology.

In this paper, we describe a proteomic approach to study viral infection (quantitative temporal viromics, QTV), based on precise temporal quantitation of plasma membrane (PM) and intracellular proteins. We combined plasma membrane profiling, our recently described method for isolation of highly purified PM proteins for proteomic analysis ([@bib47]), with study of whole-cell lysates (WCL). We quantified proteins from up to ten samples using isobaric chemical tags (tandem mass tags, TMT) ([@bib22]) and MS3 mass spectrometry. This utilizes two consecutive peptide fragmentation steps to liberate TMT reporters, minimizing interference from coisolated ions and enabling uniquely precise quantitative measurement of protein abundances at a near-global proteomic scale ([@bib41]). We quantified \>8,000 proteins including 1,184 cell-surface proteins and 81% of all canonical HCMV proteins over eight time points during productive infection, providing a near-complete temporal view of the host proteome and HCMV virome. Quantitative temporal viromics provides a framework for the study of any virus, enabling in-depth analysis of key aspects of viral pathogenesis.

Results {#sec2}
=======

Validation of Quantitative Temporal Viromics {#sec2.1}
--------------------------------------------

We infected primary human fetal foreskin fibroblasts (HFFFs) with HCMV strain Merlin and initially used 8-plex TMT to quantify changes in PM protein expression. We assessed in biological duplicate three of the reference time points in productive HCMV infection and mock infection (experiment "PM1", [Figure 1](#fig1){ref-type="fig"}A). We quantified 927 PM proteins ([Figure S1](#figs1){ref-type="fig"}A available online). Surprisingly, 56% of proteins changed \>2-fold and 33% \>3-fold by 72 hr of infection. Replicates clustered tightly ([Figure 1](#fig1){ref-type="fig"}B).

We previously demonstrated that HCMV protein UL138 degrades the cell-surface ABC transporter Multidrug Resistance-associated Protein-1 (ABCC1) in both productive and latent infections and showed that the ABCC1-specific cytotoxic substrate Vincristine could be used therapeutically to eliminate cells latently infected with HCMV ([@bib48]). To validate findings in this present study of productive infection, we examined all quantified ABC transporters and found selective downregulation of ABCC1 as well as ABCC3 ([Figure 1](#fig1){ref-type="fig"}C). The ABCC3 drug transporter might represent an additional therapeutic target.

We further validated our results by comparison to all PM proteins that exhibit reported changes during productive HCMV infection in fibroblasts. We observed expected changes in 21/22 cellular proteins ([Table S1](#mmc2){ref-type="supplementary-material"}A; [Figure S1](#figs1){ref-type="fig"}B) and detected six of six previously reported HCMV proteins at the PM. Five of these are virion envelope glycoproteins expressed late in infection ([Figure 1](#fig1){ref-type="fig"}D).

Temporal analysis of whole-cell lysates (WCLs) of HCMV-infected HFFFs enables the study of changes in expression of all proteins during infection and a comparison of the total abundance of a given protein to its expression at the PM. By analyzing WCL of HFFF infected simultaneously with PM samples, we again saw a high degree of reproducibility among biological replicates (experiment WCL1, [Figures 1](#fig1){ref-type="fig"}E and [S1](#figs1){ref-type="fig"}C) and confirmed changes in 31/35 previously reported proteins ([Table S1](#mmc2){ref-type="supplementary-material"}B). We further validated our findings by comparison to a high-throughput western blot analysis of cells infected with Toledo strain of HCMV ([@bib34]) and saw a strong association between protein changes in both experiments (p \< 0.0001, Fisher's exact test, [Table S1](#mmc2){ref-type="supplementary-material"}C).

QTV to Screen for Antiviral Factors and Interferon-Induced Genes {#sec2.2}
----------------------------------------------------------------

To gain a more detailed view of changes in the host cell proteome and HCMV virome over the course of a productive infection, and to focus on events early in infection such as the IFN response, we used 10-plex TMT ([@bib22]). We analyzed productively infected HFFFs at seven time points, plus a duplicate mock infection ([Figure S1](#figs1){ref-type="fig"}D). For the tenth sample, we analyzed 12 hr infection with irradiated virus, in which viral DNA is inactivated, allowing for infection but preventing viral gene expression ([@bib38]). Comparison of early productive infection and infection with irradiated virus allowed us to dissect the contribution of the virion to changes in the cellular proteome.

We quantified 1,184 PM proteins (experiment PM2, [Figure S1](#figs1){ref-type="fig"}E) and 7,491 cellular proteins (experiment WCL2, [Figure 2](#fig2){ref-type="fig"}A). Protein temporal profiles correlated well between repeat time courses ([Figures 1](#fig1){ref-type="fig"}F and [S1](#figs1){ref-type="fig"}F). Data from all four experiments are shown in [Table S2](#mmc3){ref-type="supplementary-material"}, where the worksheet "Plots" is interactive, enabling generation of overlayed temporal graphs of PM and WCL expression of any of the human and viral proteins quantified.

Antiviral IFN effects are conferred by interferon-stimulated gene (ISG) products that target different stages of virus replication and include known herpesvirus restriction factors Viperin and IFI16 ([@bib11]). HCMV infection triggers expression of ISG, which the virus counters by impairing the IFN signaling pathway, degrading the double-stranded RNA sensor RIG-I (Retinoic acid-inducible gene I) and "repurposing" ISGs such as Tetherin to enhance rather than restrict viral replication (reviewed in [@bib3]). The temporal effects of these strategies on ISG protein expression are poorly understood as are the HCMV proteins responsible, although the immediate early proteins IE1 and IE2 and the apoptosis inhibitory protein vMIA have been implicated ([@bib3]).

One cluster of 40 proteins from experiment WCL2 (cluster A) exhibited striking upregulation at 6 and 12 hr after infection, followed by rapid return to near-basal levels ([Figures 2](#fig2){ref-type="fig"}A and 2B). Fourteen were viral proteins, and 26/40 were human, of which 85% are already known to be interferon responsive. Seventy-three percent of these proteins are additionally known to have antiviral function ([Table S3](#mmc4){ref-type="supplementary-material"}A).

We therefore performed a comprehensive search of all other known interferon-induced antiviral genes, to determine which might be similarly or otherwise modulated during HCMV infection ([@bib8; @bib32]). Our results were consistent with the reported degradation of RIG-I and of the nuclear HCMV restriction factor Sp100 during infection ([Figures 2](#fig2){ref-type="fig"}A and [S2](#figs2){ref-type="fig"}A, respectively) ([@bib18; @bib33]). Many of the tripartite motif-containing proteins (TRIMs) are interferon induced. TRIM5α can restrict HIV, although no viral factor is yet known to antagonize its expression ([@bib31]). We quantified 21 TRIMs, of which TRIM 5, 16, 22, and 38 were downregulated during infection ([Figure S2](#figs2){ref-type="fig"}B). SAM Domain and HD Domain 1 (SAMHD1), zinc finger CCCH-type, antiviral 1 (ZAP/ZC3HAV1), and the novel anti-HIV factor Schlafen 11 (SLFN11) behaved similarly to members of cluster A ([Figure S2](#figs2){ref-type="fig"}A). It remains to be determined whether any of these antiviral proteins can restrict HCMV, and if reduction in their expression simply reflects diminished IFN signaling and response, or selective targeting by virus.

The relative contribution to ISG expression of active HCMV transcription (sensed, for example, by RIG-I) and viral binding to pattern recognition receptors (such as Toll-like receptor 2) is poorly understood ([@bib27]). We identified a group of 84 proteins significantly upregulated during productive infection, of which only 20% were \>2-fold upregulated by irradiated virus ([Figure 2](#fig2){ref-type="fig"}C; [Table S3](#mmc4){ref-type="supplementary-material"}B). The 84 proteins include 25/26 human proteins from cluster A, and 39% are known to be upregulated by IFN. Transcriptionally active HCMV may thus play an important role in ISG induction.

QTV Identifies Down- or Upregulated Signaling Pathways {#sec2.3}
------------------------------------------------------

The activity of a signaling pathway can be modulated either by posttranslational modification, or regulation of expression of a pathway member. Changes in protein expression can be quantified by QTV. We have shown that after an initial activation, the expression of ISG is rapidly reduced during HCMV infection, but how is this achieved? We quantified 13/15 key members of IFN induction and signaling pathways ([Figure 3](#fig3){ref-type="fig"}A, reviewed in [@bib3]). We confirmed known effects of HCMV infection on Jak1, STAT2, and IRF9 ([@bib20]) and demonstrated that, apart from STAT1, expression of the final effectors in both interferon induction and response pathways were all progressively diminished during infection ([Figure 3](#fig3){ref-type="fig"}A). An effect of HCMV infection on IRF3 has not previously been reported.

The k-means method is useful to cluster proteins into a specified number of classes based on the similarity of temporal profiles. We clustered all 7,491 proteins from experiment WCL2 and 1,184 proteins from PM2 into three classes (corresponding to upregulation, downregulation, and no change) to identify novel pathways dysregulated during HCMV infection ([Figure 3](#fig3){ref-type="fig"}B). We then applied DAVID software ([@bib13]) to determine which KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways were enriched in each class ([Figures 3](#fig3){ref-type="fig"}C and [S3](#figs3){ref-type="fig"}A). We made the discovery that multiple members of the TLR signaling pathway were downregulated ([Figures S3](#figs3){ref-type="fig"}A and S3B; [Table S4](#mmc5){ref-type="supplementary-material"}A), suggesting that HCMV might employ a number of strategies to avoid this intrinsic immune mechanism. Fatty acid metabolism and oxidative phosphorylation were upregulated during infection ([Figure 3](#fig3){ref-type="fig"}C; [Table S4](#mmc5){ref-type="supplementary-material"}A), corresponding to published literature ([@bib19]).

A lack of gap junction intercellular communication is common in cancer, and is thought to enable escape of homeostatic control. Gap junction alpha-1 protein (GJA1) modulates the expression of many genes involved in cell-cycle control and tumorigenesis and is degraded by HCMV IE1 and IE2 ([@bib17; @bib34]). We confirmed GJA1 downregulation and found multiple other members of the gap junction signaling pathway similarly changed ([Figure S3](#figs3){ref-type="fig"}B; [Table S4](#mmc5){ref-type="supplementary-material"}A).

The KEGG pathways "colorectal cancer" and "pathways in cancer" were enriched in the downregulated PM cluster and included Frizzled receptors FZD1, 2, 4, 6, and 7 and signaling protein WNT5a, all key members of the wnt pathway. We additionally discovered downregulation of the canonical wnt pathway coreceptors LRP5 and 6, and of noncanonical receptors ROR1, ROR2, RYK, and PTK7. Overall, 11/13 quantified wnt receptors were downmodulated ([Figure S3](#figs3){ref-type="fig"}D). Diminished transcription of wnt target genes and increased degradation of the key wnt mediator β-catenin have been reported in HCMV infection; however, the underlying mechanism is unclear ([@bib4]). Our discovery of downregulation of the majority of all wnt receptors suggests that diminished basal signaling from the cell surface may lead to increased proteasomal β-catenin degradation. Multiple effects on different cell-surface receptors suggest that the modulation of this signaling pathway may be of paramount importance to HCMV.

In order to expand our search, we performed gene set enrichment analysis (GSEA) based on the average k-means profiles for up-and downregulated WCL clusters ([Figure 3](#fig3){ref-type="fig"}B) ([@bib37]). GSEA can increase the power to detect enrichment because it scores pathways based on similarity of protein members to a prototypic profile, as opposed to determining enrichment within a large group of proteins with broadly similar profiles. Multiple mitochondrial metabolic and biosynthetic pathways were significantly upregulated and confirmed the changes we observed in fatty acid metabolism and oxidative phosphorylation. Transcription and export of mRNA was upregulated. Downregulated pathways included Robo receptor signaling, important in cell proliferation and motility, and ERBB and VEGFR signaling ([Table S4](#mmc5){ref-type="supplementary-material"}B).

Discovery of NK and T Cell Ligands and Families of Other Cell-Surface Receptors/Ligands Modulated by HCMV Infection {#sec2.4}
-------------------------------------------------------------------------------------------------------------------

We mined our data for all known NK cell ligands ([@bib46]) and discovered previously unrecognized modulation of six ligands during HCMV infection. E-cadherin (CDH1), the ligand for the inhibitory NK receptor KLRG-1 (killer cell lectin-like receptor subfamily G member 1), was dramatically upregulated during infection. Vascular cell adhesion molecule 1 (VCAM1) and B7-H6, ligands for activating NK receptors α4β1 integrin and NKp30, were downregulated ([Figure 4](#fig4){ref-type="fig"}A). Interestingly, other known ligands including collagen I (COL1A1 and COL1A2), collagen III (COL3A1), cell adhesion molecule-1 (CADM1), and poliovirus receptor-related 1 (PVRL1) were expressed in a manner that would be expected for an appropriate response to intracellular infection ([Figure 4](#fig4){ref-type="fig"}A; [Table S2](#mmc3){ref-type="supplementary-material"}).

We performed a similar screen for all known αβ T cell costimulatory molecules, and γδ T cell ligands ([@bib5; @bib14]). The T cell costimulators ICOSLG (inducible T cell costimulator ligand) and PD-L2 were downregulated during infection, as was butyrophilin subfamily 3 member A1 (BTN3A1), recently shown to present phosphoantigens to Vγ9Vδ2^+^ T cells ([@bib45]). V-domain Ig suppressor of T cell activation (VISTA, C10Orf54), a novel B7 family inhibitory ligand ([@bib6]) was upregulated late in infection ([Figure 4](#fig4){ref-type="fig"}B).

NK and T cell ligands belong to a few key protein families, including cadherins, C-type lectins, immunoglobulin, TNF receptor, and major histocompatibility-complex-related molecules ([@bib46]). In order to discover immunomodulating proteins, we added InterPro functional domain annotations to data from experiments PM1 and PM2 ([@bib15]) and reasoned that modulation of a ligand during HCMV infection may indicate biological importance. Seventy-four proteins had a relevant InterPro annotation and at least a 4-fold change compared to mock infection ([Table S5](#mmc6){ref-type="supplementary-material"}A; [Data S1](#mmc1){ref-type="supplementary-material"}). Eight downregulated proteins were protocadherins. Examining all quantified proteins in this family, we found that six of six γ-protocadherins were particularly potently downregulated ([Figure 4](#fig4){ref-type="fig"}C). The protocadherins may therefore represent a major set of immunomodulators.

We confirmed temporal profiles of protocadherins PCDHγC3 and FAT1 in addition to eight other cell-surface proteins by flow cytometry and immunoblot ([Figures 4](#fig4){ref-type="fig"}D and [S4](#figs4){ref-type="fig"}A, S4C, and S4E). To provide proof-of-principle validation of our functional predictions, we performed siRNA-mediated knockdown of the C-type lectin CLEC1A ([Table S5](#mmc6){ref-type="supplementary-material"}A), which is downregulated 7-fold by HCMV and is a potential NK ligand by homology to CLEC2D. Polyclonal NK-cells from three of three independent donors demonstrated reduced degranulation to autologous targets upon knockdown of CLEC1A suggesting that this molecule may be a novel activating NK ligand ([Figure S4](#figs4){ref-type="fig"}D). We observed similar results for the protocadherin FAT1, providing initial confirmatory evidence that members of this family may indeed be involved in immunoregulation ([Figure S4](#figs4){ref-type="fig"}E). CEACAM-1 (immunoglobulin family) was upregulated 20-fold by HCMV infection and may have roles in T cell regulation. Using a blocking antibody, we demonstrated increased degranulation of CD8^+^ T cells specific for an HCMV HLA-A2 restricted peptide epitope suggesting that upregulation of this molecule in infected cells may inhibit cytotoxic T cell-mediated lysis ([Figure S4](#figs4){ref-type="fig"}F).

There is increasing evidence for a substantial role of plexin-semaphorin signaling in the immune system ([@bib39]). For example, secreted class III semapohrins bind plexins A and D1 to regulate migration of dendritic cells to secondary lymphoid organs. Plexin B2 interacts with membrane-bound semaphorin 4D to promote epidermal γδ T cell activation ([@bib50]). HCMV infection substantially downregulated five of the nine plexins: A1, A3, B1, B2, and D1. Intriguingly, neuropilin 2, a plexin coreceptor was also rapidly downregulated. Semaphorin 4D was dramatically upregulated and 4C downregulated, suggesting that viral interaction with these ligands is complex ([Table S5](#mmc6){ref-type="supplementary-material"}A; [Data S1](#mmc1){ref-type="supplementary-material"}).

To determine which protein domains and biological processes were enriched within highly downregulated PM proteins, we used DAVID software ([@bib13]). The Interpro categories "protocadherin gamma" and "immunoglobulin-like fold" were significantly enriched in addition to Gene Ontology (GO) biological processes "regulation of leukocyte activation" and "positive regulation of cell motion," suggesting a negative effect of HCMV on cell motility. DAVID analysis also revealed families of downregulated proteins, including six G-protein-coupled receptors from the rhodopsin-like superfamily ([Table S5](#mmc6){ref-type="supplementary-material"}B).

Within the category "regulation of leukocyte activation," ephrin B1 was downregulated, and we therefore examined all ephrins and their receptors. We observed striking downregulation of ephrins B1 and B2 as well as all three of their quantified B-class ephrin receptors ([Data S1](#mmc1){ref-type="supplementary-material"}). Downstream effects of forward or reverse ephrin signaling include changes in cell adhesion, shape, and motility, and there is evidence for a role of ephrin B2 in murine T cell costimulation ([@bib25]), suggesting that downregulation of this pathway may represent another mechanism of immune evasion.

Temporal Analysis of HCMV Viral Protein Expression {#sec2.5}
--------------------------------------------------

Most prior studies of the temporal expression of canonical HCMV proteins have employed immunoblots at only one or a few time points. Comparison between different reports has been complicated by lack of specific antibodies and study-to-study variation in the HCMV strain used, with laboratory-adapted strains AD169 and Towne (which lack a large number of ORFs as a result of extensive passage in vitro) often used in preference to isolates containing a complete genome ([@bib21]). We were able to quantify the temporal expression of the majority (139/171) of the canonical HCMV proteins as well as 14 noncanonical ORFs; most of these proteins were quantified in a single experiment ([Figure 5](#fig5){ref-type="fig"}, plots for all quantified viral proteins in [Data S1](#mmc1){ref-type="supplementary-material"}).

IE/E/E-L/L cascades are functionally defined by the use of metabolic inhibitors. IE transcripts accumulate in the presence of a protein synthesis inhibitor such as cycloheximide. Expression of early genes is unaffected by viral DNA synthesis inhibitors such as Phosphonoformate (PFA), whereas E-L genes are partially inhibited, and L genes completely inhibited ([@bib7]).

A complementary method of classification would be to group viral proteins according to their temporal profiles. Use of the k-means method with four classes suggested that HCMV protein profiles grouped similarly to the recognized functional cascades IE/E/E-L/L ([Figure 5](#fig5){ref-type="fig"}A). We performed k-means clustering with 2 to 14 classes and assessed the summed distance of each protein from its cluster centroid. Although this summed distance necessarily becomes smaller as more clusters are added, the rate of decline decreases with each added group, eventually settling at a fairly constant rate of decline that reflects overfitting; clusters added prior to this point reflect underlying structure in the temporal protein data, whereas clusters subsequently added through overfitting are not informative. The point of inflexion fell between five and seven classes, suggesting that there are at least five distinct temporal protein (Tp) profiles of viral protein expression ([Figures 5](#fig5){ref-type="fig"}A--5D). We term these classes Tp1, Tp2, Tp3, Tp4, and Tp5. There was generally good correspondence between classical functional and protein temporal classes, for example, the known L proteins UL99, UL94, UL75, UL115, and UL32 all classified as Tp5 ([@bib26]). A cluster of 13 proteins that we call Tp4 exhibited a distinct profile to Tp3 and Tp5, with maximal expression at 48 hr and low expression at other time points ([Figures 5](#fig5){ref-type="fig"}C and 5D). Members of this cluster predominantly originated from two regions of the viral genome ([Table S6](#mmc7){ref-type="supplementary-material"}A).

To directly compare classical functional and protein temporal classes, we performed WCL analysis in the presence or absence of the viral DNA replication inhibitor PFA (experiment WCL3, [Figures 5](#fig5){ref-type="fig"}C and 5D; [Table S2](#mmc3){ref-type="supplementary-material"}; plots for all quantified viral proteins in [Data S1](#mmc1){ref-type="supplementary-material"}). Expression of 48/55 Tp5-class proteins was completely or almost completely inhibited by PFA. Tp3 and Tp4 proteins were generally partially inhibited, with little effect on Tp1 or Tp2. Some proteins displayed more complex profiles, with enhanced expression later in infection with PFA block ([Data S1](#mmc1){ref-type="supplementary-material"}).

Eight proteins appear earlier in infection than had previously been understood. UL27, UL29, UL135, UL138, US2, US11, US23, and US24 all exhibited peak expression at 6--18 hr after infection ([Figure 5](#fig5){ref-type="fig"}C). UL29 and US24 appeared particularly early, with peak expression at only 6 hr postinfection, which may correspond with their suggested ability to stimulate IE gene expression ([@bib10; @bib40]).

We were unable to confidently resolve the profile of UL122 (IE2). UL122 and UL123 are expressed by alternative splicing of a single major immediate-early transcript. Exons 1, 2, 3, and 4 encode UL123 and exons 1, 2, 3, and 5 encode UL122; however, additional transcripts have also been detected from the region of exon 5 ([@bib35; @bib36]). We examined each peptide quantified from every exon ([Figure S5](#figs5){ref-type="fig"}A). The profiles of all peptides from exon 4 peaked at 18--24 hr, corresponding to the predicted expression of UL123 protein. The profiles of ten exon 5 peptides corresponding to the late-expressed internal ORF, ORFL265C.iORF1 ([@bib36]) peaked at 96 hr. A single peptide N-terminal to this ORF that is likely to originate from UL122 had a distinct profile with expression from 6 hr that peaked at 48 hr, similar to UL122 mRNA ([@bib36]). This suggests the existence of at least two proteins arising wholly or in part from exon 5 and corresponds to the detection of an abundant late 40 kDa protein, previously detected from the same internal exon 5 ORF of AD169 strain ([@bib35]). It is likely that ORFL265C.iORF1 protein is more abundant than UL122, effectively masking the earlier signal from most UL122 exon 5 peptides. Our quantitation of DNA polymerase processivity subunit UL44 may similarly have been complicated due to multiple transcription start sites ([Data S1](#mmc1){ref-type="supplementary-material"}).

We further compared our protein-level data with recent RNA-sequencing-based temporal analysis of HCMV Merlin strain transcripts at 5, 24, and 72 hr postinfection in HFFF ([@bib36]). We again used 5 k-means classes to group transcripts based on their temporal profiles ([Figure S5](#figs5){ref-type="fig"}C). Because there were no intermediate mRNA time points between 5 and 24 hr, or between 24 and 72 hr, there was insufficient information to make an accurate comparison between the central three mRNA clusters and our Tp2, Tp3, or Tp4 class proteins. We therefore used mRNA data to define three classes: Tr1, Tr2--4, and Tr5 ([Figure S5](#figs5){ref-type="fig"}C). Comparison to our protein data was striking: 10/13 Tp1 proteins were also Tr1 transcripts and 49/55 Tp5 proteins were Tr5 transcripts (p \< 0.0001, Fisher's exact test) ([Table S6](#mmc7){ref-type="supplementary-material"}C; [Figure S5](#figs5){ref-type="fig"}D). Such correspondence between different studies targeting distinct classes of biomolecules suggests that the temporal classes of HCMV gene expression we define are likely to be biologically relevant.

We quantified the full temporal profiles of nine noncanonical HCMV ORFs. Four ORFs related to canonical HCMV proteins (N-terminal extension, internal ORF, C-terminal extension) and demonstrated similar temporal profiles to their canonical counterparts ([Figure S5](#figs5){ref-type="fig"}B; [Data S1](#mmc1){ref-type="supplementary-material"}). Five ORFs were encoded either in different reading frames, or on the reverse strand to canonical genes ([Table S6](#mmc7){ref-type="supplementary-material"}B). We additionally quantified five further noncanonical ORFs in experiment WCL3 ([Data S1](#mmc1){ref-type="supplementary-material"}).

HCMV Proteins Present at the Cell Surface {#sec2.6}
-----------------------------------------

Viral proteins present at the surface of an infected cell may be therapeutic antibody targets. To date, only six HCMV proteins have been demonstrated at the PM of infected fibroblasts, all late in infection, which we have confirmed ([Figure 1](#fig1){ref-type="fig"}D). Several other studies transduced individual viral genes and demonstrated protein appearance at the cell surface, which can indicate but may not reflect protein location during productive infection ([Table S7](#mmc8){ref-type="supplementary-material"}).

We detected a total of 67 viral proteins in experiments PM1 and PM2. Plasma membrane profiling provides a very substantial enrichment for PM glycoproteins (up to 90% of proteins from unfractionated samples, and approximately 60% of proteins from fractionated samples have indicative Gene Ontology (GO) terms ([Figure S1](#figs1){ref-type="fig"}A) ([@bib47]). Subcellular localization of viral proteins is, however, poorly annotated, making it difficult to determine which might be non-PM contaminants, such as abundant viral tegument and nuclear proteins. We therefore developed a filtering strategy: for every GO-annotated human protein quantified in experiment PM1 or PM2 ([Figure S1](#figs1){ref-type="fig"}A), we calculated the ratio of peptides (experiments PM1 + PM2)/(experiments WCL1+WCL2). Ninety-two percent of proteins that were GO-defined non-PM had a ratio of \<1.4; 88% of human proteins scoring above 1.4 were annotated as PM proteins, demonstrating the predictive value of this metric ([Figure 6](#fig6){ref-type="fig"}A). Applying this filter, we defined 29 high-confidence viral PM proteins, which included the majority of viral proteins previously identified at the surface of either infected or transduced cells, and excluded all proteins unlikely to be present at the cell surface based on their known function ([Table S7](#mmc8){ref-type="supplementary-material"}).

In general, we observed a striking correlation between the PM2 and WCL2 temporal profiles of all 29 high-confidence proteins. For the subset of known virion envelope glycoproteins ([@bib44]), protein expression at the PM was significantly later than in WCL, confirmed by analysis of the same proteins from experiments PM1 and WCL1 ([Figures 6](#fig6){ref-type="fig"}B and [S6](#figs6){ref-type="fig"}). This may reflect assembly of the HCMV virion within the viral cytoplasmic assembly compartment prior to viral egress ([@bib2]) and demonstrates that QTV can additionally provide insights into aspects of the viral life cycle. PM appearance of UL119 was similarly delayed, suggesting that this known virion glycoprotein may be a component of the virion envelope. The sensitivity of MS3 TMT-based mass spectrometry is suggested by our apparent quantitation of binding or fusion of viral envelope with the plasma membrane; there was a small early peak in PM presence of most virion envelope glycoproteins at 6 hr of infection that disappeared by 12 hr ([Figure 6](#fig6){ref-type="fig"}B).

QTV Indicates Mechanism of Action of Viral Proteins {#sec2.7}
---------------------------------------------------

We have previously shown that HCMV UL141 retains the poliovirus receptor (PVR) in the endoplasmic reticulum, inhibiting cell-surface expression and preventing interaction with activating NK receptor DNAM-1. Intracellular PVR accumulates during HCMV infection. In contrast, a second DNAM-1 ligand poliovirus receptor-related 2 (PVRL2) is targeted for proteasomal degradation by UL141 acting with other HCMV gene(s) ([@bib30; @bib42]). QTV confirmed these results; we observed rapid depletion of PVR from the plasma membrane, in contrast to its accumulation within WCL. PVRL2 was lost from both PM and WCLs ([Figure 7](#fig7){ref-type="fig"}). The WCL kinetics of UL141 expression paralleled that of PVR but were inversely related to PVRL2.

The activating receptor NKG2D is expressed on a variety of immune effector cells and recognizes major histocompatibility complex class I-related ligands MICA, MICB, and ULBP1-3. HCMV infection strongly induces transcription of MICB, ULBP1, and ULBP2 mRNA but prevents their surface expression by intracellular sequestration with HCMV UL16 ([@bib9]). Our data were highly consistent with this literature. Interestingly, cell-surface expression of ULBP1 and -2 rose late in infection, suggesting that UL16 had become overwhelmed ([Figure 7](#fig7){ref-type="fig"}A).

We therefore examined other HCMV proteins known to target cell-surface receptors ([Table S1](#mmc2){ref-type="supplementary-material"}A). The profiles of UL138 and ABCC1 were consistent with their codegradation ([@bib48]), and the profile of HLA-A reflected US2 and US11-mediated degradation ([Figure 7](#fig7){ref-type="fig"}B). Other examples are shown in [Figures S7](#figs7){ref-type="fig"}A and S7B. The temporal profiles provided by QTV are thus useful to gain mechanistic insights into known interactions between viral and host proteins.

Discussion {#sec3}
==========

In this study, we provide a comprehensive resource describing temporal changes in viral and host proteomes during infection with HCMV. Simultaneous study of protein expression at the cell surface and in whole-cell lysates has revealed insights into many aspects of the viral life cycle. To be able to persist in an infected individual lifelong, herpesviruses have developed a wealth of strategies to modulate innate and adaptive immunity. One benefit is that we can use HCMV infection to discover proteins important in host defense, as viral modulation of protein expression generally reflects biological imperative. We often observed modulation of multiple members of the same protein family, increasing the likelihood of biological relevance; for example, six of six γ-protocadherins that are downregulated during infection may be novel NK ligands in addition to protocadherin FAT1. The correspondence in temporal profiles of proteins in cluster A ([Figure 2](#fig2){ref-type="fig"}A) enables prediction of IFN-stimulated genes, which might additionally have antiviral function. Multiple signaling pathways were modulated by HCMV, which has the potential to inform not only viral interaction networks by predicting effects on pathway target genes but improves our knowledge of the metabolic changes necessary to effect viral replication ([@bib19]). GSEA provides a particularly useful overview of many of the pathways and receptors changing significantly in our data.

The temporal quantitation of \>80% of canonical HCMV proteins in one experiment provides a significant technical advance. Our knowledge of HCMV protein profiles has so far relied on a literature complicated by the use of multiple different laboratory-adapted viral strains, different cell types, and variable infection conditions ([@bib21]). Many have not previously been quantified. We provide a temporal system of classification of HCMV protein expression using the prototype clinical strain Merlin, which is complementary to and consistent with the functionally derived classical IE/E/E-L/L nomenclature. For example, expression of 87% of proteins we define as Tp5 was prevented by the viral DNA replication inhibitor PFA. These data suggest that the classical "true late" category of transcripts could be substantially expanded. Furthermore, all capsid proteins we quantified ([@bib23]) belonged to class Tp5, whereas viral tegument proteins were more diverse: of 27 quantified, three were Tp1, 2 Tp2, 8 Tp3, and 14 Tp5, suggesting that these proteins may additionally have nonstructural roles such as regulation of gene expression and immune evasion. It remains to be seen whether Tp4 proteins have a distinct function that requires peak expression at 48 hr of infection, for example, preparation of the cell for virus release via inhibition of neutralizing antibody and cellular immunity (RL11 family), or promoting viral egress and cell-cell spread ([Table S5](#mmc6){ref-type="supplementary-material"}A). Particular advantages to our temporal measurements include the ability to correlate viral and cellular protein expression, narrowing the field of viral proteins possibly responsible for target modulation and in some cases indicating mechanism. The utility of QTV could be extended by simultaneous transcriptomic studies; if a host protein is downregulated, is this due to diminished gene expression, or posttranscriptional effects such as protein degradation?

In their recent ribosomal profiling (RP) analysis of HCMV, [@bib36] identified 147/171 canonical genes. We quantified 139/171 proteins ([Table S2](#mmc3){ref-type="supplementary-material"}), notably including 15 genes not detected by RP. Proteins UL1 and UL6 were quantified at the PM but not in WCL samples suggesting that overall abundance of both mRNA and protein might be low. It is unclear why RP failed to detect the 13 remaining proteins, which in several cases we quantified by abundant peptides. It is likely that the sensitivity of QTV for low-abundant proteins will be further increased with the next generation of Orbitrap mass spectrometers, enabling an even more comprehensive coverage of both HCMV and human proteomes. For example, analysis of experiment WCL3 using the new Orbitrap Fusion enabled quantitation of five noncanonical ORFs we previously did not detect. Even with this sensitive instrument, it is still possible that we were unable to detect very low-abundant proteins, which may explain why some studies have detected viral transcripts earlier in infection that our protein measurements suggest. An increase in proteome coverage will also improve our ability to distinguish protein isoforms, which complicated our quantitation of UL122.

With an increasing frequency of transplantation and emergence of drug resistance, novel strategies are required to treat HCMV infection. QTV provides evidence for up to 29 cell-surface viral glycoproteins that can now be assessed as targets for therapeutic monoclonal or bispecific antibodies, to stimulate antibody-dependent cellular cytotoxicity or deliver a cytotoxin. Strongly upregulated PM proteins may constitute alternative antibody targets. By directing treatment toward proteins expressed early in infection, it may be possible to eliminate infected cells prior to the release of infectious virus. The efficacy and safety of such an approach is suggested by small-scale treatment of patients with severe drug-resistant HCMV disease using pooled immunoglobulin selected for high antibody titers to HCMV ([@bib1]). QTV has demonstrated great utility in being able to identify and quantify the regulation of virus and host proteins on the cell surface without requirement for specific antibodies. Clearly, the cell-surface viral proteins we describe require validation using an independent approach once reagents are available.

QTV is applicable to any virus, or indeed any intracellular pathogen with a robust in vitro model and has the potential to improve our understanding of infection.

Experimental Procedures {#sec4}
=======================

Brief descriptions of key experimental procedures are provided below. For complete details, see [Extended Experimental Procedures](#dtbox1){ref-type="boxed-text"}.

Virus Infections {#sec4.1}
----------------

Twenty-four hours prior to each infection, 1.5 × 10^7^ HFFFs were plated in a 150 cm^2^ flask. Cells were sequentially infected at multiplicity of infection 10 with HCMV strain Merlin. Greater than 95% of cells were routinely infected using this approach ([Figures S4](#figs4){ref-type="fig"}A and S4B). Infections were staggered such that all flasks were harvested simultaneously. For 12 hr irradiated virus infection, virus was gamma irradiated with a dose of 3,500 Gy.

Protein Isolation and Peptide Labeling with Tandem Mass Tags {#sec4.2}
------------------------------------------------------------

Plasma membrane profiling was performed as described previously ([@bib47]). One hundred percent of each peptide sample was labeled with TMT reagent, and six fractions were generated from combined peptide samples by tip-based strong cation exchange. For whole-proteome analysis, cells were lysed and protein was reduced and then alkylated. Protein was digested with LysC (experiment 1) or LysC and then Trypsin (experiments 2 and 3). Peptides were labeled with TMT reagent, and 12 fractions were generated by high-pH reverse-phase HPLC.

Mass Spectrometry and Data Analysis {#sec4.3}
-----------------------------------

We performed mass spectrometry using an Orbitrap Elite (experiments 1 and 2) or an Orbitrap Fusion (experiment WCL3) and quantified TMT reporter ions from the MS3 scan ([@bib22; @bib41]). Peptides were identified and quantified using a Sequest-based in-house software pipeline. A combined database was searched, consisting of (1) human Uniprot, (2) Merlin strain HCMV Uniprot, and (3) all additional noncanonical HCMV ORFs ([@bib36]). Peptide-spectral matches were filtered to a 1% false discovery rate (FDR) using linear discriminant analysis in conjunction with the target-decoy method ([@bib16]). The resulting data set was further collapsed to a final protein-level FDR of 1%. Protein assembly was guided by principles of parsimony. Where all PSM from a given HCMV protein could be explained either by a canonical gene or noncanonical ORF, the canonical gene was picked in preference. Proteins were quantified by summing TMT reporter ion counts across all matching PSM after filtering based on isolation specificity ([@bib28]). Reverse and contaminant proteins were removed, and protein quantitation values were exported for normalization and further analysis in Excel. Hierarchical clustering was performed using centroid linkage with Pearson correlation unless otherwise noted. One-way ANOVA was used to identify proteins differentially expressed over time in experiments PM1 and WCL1, and p values were corrected for multiple testing using the method of Benjamini-Hochberg. Other statistical analysis was performed using XLStat.

NK and T Cell CD107a Mobilization Assays {#sec4.4}
----------------------------------------

NK and T cell degranulation assays were performed in a similar manner to that described previously ([@bib30]). These protocols were approved by the Cardiff University School of Medicine Ethics Committee Ref. no: 10/20.

Extended Experimental ProceduresMaterialsTandem mass tag (TMT) 8-plex and 10-plex isobaric reagents were from Thermo Scientific, (Rockford, IL) ([@bib196]). Water and organic solvents were form J.T. Baker (Center Valley, PA). Unless otherwise noted, all other chemicals were from Sigma-Aldrich (St. Louis, MO).Cells and VirusesPrimary human fetal foreskin fibroblast cells (HFFF) were grown in Dulbecco's modified eagles medium (DMEM) (Life Technologies) supplemented with fetal bovine serum (10% v/v), penicillin/streptomycin and L-glutamine (GIBCO) at 37°C in 5% CO~2~. Cells were verified to be mycoplasma negative. The HCMV strain Merlin is designated the reference HCMV genome sequence by the National Center for Biotechnology Information and was sequenced after only 3 passages in vitro ([@bib90]). We recently constructed a BAC clone containing the complete Merlin genome to provide a reproducible source of genetically intact, clonal virus for pathogenesis studies ([@bib183]). Merlin BAC derived clone RCMV1111 used for this study contains point mutations in RL13 and UL128, enhancing replication in fibroblasts ([@bib183]). Generation of virus stocks by BAC transfection into fibroblasts was as previously described ([@bib183]). Virus was gamma irradiated with a dose of 3500Gy using a Gammacell 1000 Elite (Nordion International), and inactivation was verified by absence of immunofluorescence for IE1 compared to control (data not shown).Virus Infections24h prior to each infection, 1.5 × 10^7^ HFFFs were plated in a 150cm^2^ flask. Cells were sequentially infected at multiplicity of infection 10 with HCMV strain Merlin. Infections were staggered such that all flasks were harvested simultaneously. Infection efficiency was monitored using HCMV IE1 intracellular staining or MHC class-I cell surface staining and confirmed as ≥ 95% ([Figures S4](#figs4){ref-type="fig"}A and S4B). For experiment WCL3, where indicated cells were incubated with Phosphonoformate (PFA) at 300ug/ml from the time of infection onward.Plasma Membrane ProfilingPlasma membrane profiling was performed as described previously, with minor modifications for adherent cells ([@bib201; @bib47]). Briefly, one 150cm2 flask of HCMV-infected HFFFs per condition was washed twice with ice-cold PBS. Sialic acid residues were oxidized with sodium meta-periodate (Thermo) then biotinylated with aminooxy-biotin (Biotium). The reaction was quenched, and the biotinylated cells scraped into 1% Triton X-100 lysis buffer. Biotinylated glycoproteins were enriched with high-affinity streptavidin agarose beads (Pierce) and washed extensively. Captured protein was denatured with DTT, alkylated with iodoacetamide (IAA, Sigma) and digested on-bead with trypsin (Promega) in 100 mM HEPES pH 8.5 for 3h. Tryptic peptides were collected. [@bib41] suggest that LysC digestion is preferable for quantitative proteomic analysis using TMT, because it guarantees labeling of both N-termini and C-terminal lysine side chains on virtually every peptide ([@bib41]). In practice TMT labeling is compatible with analysis of even tryptic peptides that may only bear TMT labels on their N terminus.Whole-Proteome SamplesCells were washed twice with PBS, and 1 ml lysis buffer added (experiment 1: 8 M Urea/100 mM HEPES pH8.5, experiments 2, 3: 6 M Guanidine/50 mM HEPES pH8.5). Cell lifters (Corning) were used to scrape cells in lysis buffer, which was removed to an eppendorf tube, vortexed extensively then sonicated. Cell debris was removed by centrifuging at 13,000 g for 10 min twice. Protein concentrations were determined by BCA assay (Pierce). Dithiothreitol (DTT) was added to a final concentration of 5 mM and samples were incubated for 20 min. Cysteines were alkylated with 15 mM iodoacetamide and incubated 20 min at room temperature in the dark. Excess iodoacetamide was quenched with DTT for 15 min. Samples were diluted with 100 mM HEPES pH 8.5 to 4 M Urea (experiment 1) or 1.5 M Guanidine (experiments 2, 3) followed by digestion at room temperature for 3 hr with LysC protease at a 1:100 protease-to-protein ratio. For experiments 2 and 3, trypsin was then added at a 1:100 protease-to-protein ratio followed by overnight incubation at 37°C. The reaction was quenched with 1% formic acid, subjected to C18 solid-phase extraction (Sep-Pak, Waters) and vacuum-centrifuged to near-dryness. While experiment 1 employed LysC digestion as recommended by [@bib41], experiments 2 and 3 employed a modified protocol for two reasons: (i) Guanidine was found to solubilize membrane proteins better than Urea, which would facilitate comparisons with the PM data; and (ii) sequential digestion with LysC followed by Trypsin was found to provide more robust digestion across samples, frequently resulting in improved depth of proteome coverage.Peptide Labeling with Tandem Mass TagsIn preparation for TMT labeling, desalted peptides were dissolved in 100 mM HEPES pH 8.5. For whole proteome samples, peptide concentration was measured by microBCA (Pierce), and 100 μg of peptide labeled with TMT reagent. For plasma membrane samples, 100% of each peptide sample was labeled.TMT reagents (0.8 mg) were dissolved in 40 μl anhydrous acetonitrile and 10 μl (whole proteome) or 2.5 μl (PM samples) added to peptide at a final acetonitrile concentration of 30% (v/v). For experiments PM1 and WCL1, samples were labeled as follows: mock replicate 1 (TMT 126); mock replicate 2 (TMT 128); 24h infection replicate 1 (TMT 127n); 24h infection replicate 2 (TMT 127c); 48h infection replicate 1 (TMT 129n); 48h infection replicate 2 (TMT 129c); 72h infection replicate 1 (TMT 130); 72h infection replicate 2 (TMT 131). For experiments PM2 and WCL2, samples were labeled as described in [Figure S1](#figs1){ref-type="fig"}D. For experiment WCL3, samples were labeled as follows: mock (TMT 126); mock + PFA (TMT 131); 24h infection (TMT 127n); 24h infection + PFA (TMT 127c); 48h infection (TMT 128n); 48h infection + PFA (TMT 128c); 72h infection (TMT 129n); 72h infection + PFA (TMT 129c); 96h infection (TMT 130n); 96h infection + PFA (TMT 130c). Following incubation at room temperature for 1 hr, the reaction was quenched with hydroxylamine to a final concentration of 0.3% (v/v). TMT-labeled samples were combined at a 1:1:1:1:1:1:1:1 ratio (8-plex TMT, experiment 1) or 1:1:1:1:1:1:1:1:1:1 ratio (10-plex TMT, experiments 2, 3). The sample was vacuum-centrifuged to near dryness and subjected to C18 solid-phase extraction (SPE) (Sep-Pak, Waters).Offline High pH Reversed-Phase Fractionation, Whole-Proteome SamplesCombined, TMT-labeled peptide samples were fractionated using an Agilent 300Extend C18 column (5 μm particles, 4.6 mm ID, 220 mm length) and an Agilent 1100 quaternary pump equipped with a degasser and a photodiode array detector (220 and 280nm, ThermoFisher, Waltham, MA). Peptides were separated with a gradient of 5% to 35% acetonitrile in 10 mM ammonium bicarbonate pH 8 over 60 min. 96 resulting fractions were consolidated into 12, acidified to 1% formic acid and vacuum-centrifuged to near dryness. Each fraction was desalted using a StageTip ([@bib164]), dried, and reconstituted in 4% acetonitrile / 5% formic acid prior to LC-MS/MS.Offline Tip-Based Strong Cation Exchange SCX Fractionation, PM SamplesOur previously described protocol for solid-phase extraction based SCX peptide fractionation ([@bib88]) was modified for small peptide amounts. Briefly, 10 mg of PolySulfethyl A bulk material (Nest Group Inc) was loaded on to a fritted 200ul tip in 100% Methanol using a vacuum manifold. SCX material was conditioned slowly with 1 ml SCX buffer A (7 mM KH~2~PO~4~, pH 2.65, 30% Acetonitrile), then 0.5 ml SCX buffer B (7 mM KH~2~PO~4~, pH 2.65, 350 mM KCl, 30% Acetonitrile) then 2 ml SCX buffer A. Dried peptides were resuspended in 500 μl SCX buffer A and added to the tip at a flow rate of ∼150 μl/min, followed by a 150 μl wash with SCX buffer A. Fractions were eluted in 150ul buffer at increasing K^+^ concentrations (10, 25, 40, 60, 90, 150 mM KCl), vacuum-centrifuged to near dryness then desalted using StageTips.Liquid Chromatography and Tandem Mass SpectrometryMass spectrometry data were acquired using an Orbitrap Elite mass spectrometer (experiments PM1, PM2, WCL1, WCL2) coupled with a Proxeon EASY-nLC II liquid chromatography (LC) pump or an Orbitrap Fusion (experiment WCL3) coupled with a Proxeon EASY-nLC 1000 LC pump (Thermo Fisher Scientific, San Jose, CA).For Orbitrap Elite Experimentspeptides were separated on a 100 μm inner diameter microcapillary column packed with 0.5 cm of Magic C4 resin (5 μm, 100 Å, Michrom Bioresources) followed by approximately 20 cm of Maccel C18 resin (3 μm, 200 Å, Nest Group).Peptides were separated using a 3 hr gradient (WCL samples) or 2h gradient (PM samples) of 6 to 30% acetonitrile in 0.125% formic acid at a flow rate of 300 nl/min. Each analysis used an MS3-based TMT method ([@bib22; @bib41]). The scan sequence began with an MS1 spectrum (Orbitrap analysis, resolution 60,000, 300−1500 Th, AGC target 1 × 10^6^, maximum injection time 150 ms). The top ten precursors were then selected for MS2/MS3 analysis. MS2 analysis consisted of CID (quadrupole ion trap analysis, AGC 2 × 10^3^, NCE 35, q-value 0.25, maximum injection time 100 ms). MS3 precursors were fragmented by HCD prior to Orbitrap analysis (NCE 50, max AGC 1.5 × 10^5^, maximum injection time 250 ms, isolation specificity 2.5 Th, resolution 30,000) ([@bib22]).For Orbitrap Fusion Experiment WCL3peptides were separated on a 75 μm inner diameter microcapillary column packed with 0.5 cm of Magic C4 resin (5 μm, 100 Å, Michrom Bioresources) followed by approximately 20 cm of GP118 resin (1.8 μm, 120 Å, Sepax Technologies).Peptides were separated using a 3 hr gradient (WCL samples) or 2h gradient (PM samples) of 6 to 30% acetonitrile in 0.125% formic acid at a flow rate of 300 nl/min. Each analysis used an MS3-based TMT method ([@bib22; @bib41]). The scan sequence began with an MS1 spectrum (Orbitrap analysis, resolution 120,000, 400−1400 Th, AGC target 2 × 10^5^, maximum injection time 200 ms). 'Top speed' (2 s) was selected for MS2 analysis, which consisted of CID (quadrupole ion trap analysis, AGC 4 × 10^3^, NCE 35, maximum injection time 150 ms). The top ten precursors were selected for MS3 analysis, in which precursors were fragmented by HCD prior to Orbitrap analysis (NCE 55, max AGC 5 × 10^4^, maximum injection time 250 ms, isolation specificity 0.5 Th, resolution 60,000) ([@bib22]).Data AnalysisMass spectra were processed using a Sequest-based in-house software pipeline. MS spectra were converted to mzXML using a modified version of ReAdW.exe. A combined database was constructed from (a) the human Uniprot database (August 10, 2011), (b) the human cytomegalovirus (strain Merlin) Uniprot database, (c) all additional novel human cytomegalovirus ORFs described by [@bib36] and (d) common contaminants such as porcine trypsin and endoproteinase LysC. The combined database was concatenated with a reverse database composed of all protein sequences in reversed order. Searches were performed using a 20 ppm precursor ion tolerance. Product ion tolerance was set to 0.03 Th. TMT tags on lysine residues and peptide N termini (229.162932 Da) and carbamidomethylation of cysteine residues (57.02146 Da) were set as static modifications, while oxidation of methionine residues (15.99492 Da) was set as a variable modification.To control the fraction of erroneous protein identifications, we used a target-decoy strategy ([@bib94; @bib95]). Peptide spectral matches (PSMs) were filtered to an initial peptide-level false discovery rate (FDR) of 1% with subsequent filtering to attain a final protein-level FDR of 1%. PSM filtering was performed using a linear discriminant analysis, as described previously ([@bib16]), considering the following parameters: XCorr, ΔCn, missed cleavages, peptide length, charge state, and precursor mass accuracy. Protein assembly was guided by principles of parsimony to produce the smallest set of proteins necessary to account for all observed peptides. Where all PSMs from a given HCMV protein could be explained either by a canonical gene or novel ORF, the canonical gene was picked in preference.Proteins were quantified by summing TMT reporter ion counts across all matching peptide-spectral matches using in-house software, as described previously ([@bib28]). Briefly, a 0.003 Th window around the theoretical m/z of each reporter ion (126, 127n, 127c, 128n, 128c, 129n, 129c, 130n, 130c, 131) was scanned for ions, and the maximum intensity nearest to the theoretical m/z was used. The primary determinant of quantitation quality is the number of TMT reporter ions detected in each MS3 spectrum, which is directly proportional to the signal-to-noise ratio observed for each ion ([@bib136]). Conservatively, we require every individual peptide used for quantitation to contribute sufficient TMT reporter ions (minimum of ∼500 per spectrum) so that each on its own is expected to provide a representative picture of relative protein abundance ([@bib22]). We additionally employ an isolation specificity filter to minimize peptide coisolation ([@bib41]). Peptide-spectral matches with poor quality MS3 spectra (more than 9 TMT channels missing and/or a combined signal:noise ratio of less than 100 across all TMT reporter ions) or no MS3 spectra at all were excluded from quantitation. All MS2 and MS3 spectra from novel ORFs were all manually validated to confirm both identifications and quantifications. Protein quantitation values were exported for further analysis in Excel.For protein quantitation, reverse and contaminant proteins were removed, then each reporter ion channel was summed across all quantified proteins and normalized assuming equal protein loading across all 8 or 10 samples. Gene Ontology and KEGG terms ([@bib57; @bib118]) were added using Perseus version 1.4.1.3 ([@bib80]). Gene name aliases were added using GeneALaCart ([www.genecards.org](http://www.genecards.org){#intref0010}) ([@bib166]). The one-way ANOVA test was used to identify proteins differentially expressed over time in experiments PM1 and WCL1, and was corrected using the method of Benjamini-Hochberg to control for multiple testing error ([@bib63]). A Benjamini-Hochberg-corrected p value \< 0.05 was considered statistically significant. Values were calculated using Mathematica (Wolfram Research). Other statistical analyses including Principal Component analysis and k-means clustering were performed using XLStat (Addinsoft). Hierarchical centroid clustering based on uncentered Pearson correlation was performed using Cluster 3.0 (Stanford University) and visualized using Java Treeview (<http://jtreeview.sourceforge.net>) unless otherwise noted. For RNaseq data from [@bib184], mRNA reads densities from 5, 24 and 72h for each transcript were normalized to 1, and hierarchical clustering based on Euclidian distance was performed using Cluster 3.0. For comparison of experiment WCL1 to Powerblot data from [@bib34], we compared fold change at 72h for the proteins quantified by Powerblot at the highest confidence (levels 7, 8, 9, 10 \[[@bib34]\]) and determined association between protein changes using Fisher's exact test.Pathway AnalysisThe Database for Annotation, Visualization and Integrated Discovery (DAVID) was used to determine protein family and KEGG pathway enrichment ([@bib13]). A given cluster was always searched against a background of all proteins quantified within the relevant experiment. To generate KEGG pathway diagrams, human pathway information was downloaded from the KEGG database and was imported into Mathematica 9.0 (Wolfram Research), where pathways were plotted and colored according to the designation in [Figures S3](#figs3){ref-type="fig"}A and S3B.Gene Set Enrichment AnalysisGene Set Enrichment Analysis ([@bib143; @bib37]) was performed using the javaGSEA application provided by the Broad Institute (<https://www.broadinstitute.org/gsea/index.jsp>). A gene set composed of the KEGG and Reactome ([@bib82]) gene sets provided in MSigDB (c2.cp.kegg.v4.0.symbols.gmt and c2.cp.reactome.v4.0.symbols.gmt) was searched. To generate prototypical expression profiles, the mean expression values for the k-means groupings using k = 3 was calculated for both whole-cell lysate and plasma membrane protein expression values. For each of these prototype profiles, GSEA was run using Pearson correlation to the prototype as a test statistic. Because there was only one sample per time point, p-values were generated by permuting the phenotype 1,000 times. The weighted enrichment statistic was used and the signal to noise metric was used to rank the genes. We selected all pathways enriched with a Bonferroni-corrected p \< 0.005.Flow CytometryHCMV Merlin-infected 6-well dishes of HFFFs were detached with TrypLE Express (Invitrogen) or HyQTase (Thermo), washed in PBS, and resuspended in PBS + 2% fetal calf serum. Cells were incubated with primary antibody for 20--30 min on ice, followed by anti-mouse AF647 (Molecular Probes), and fixed with 1% paraformaldehyde. The following antibodies were used: anti-PD-L1 (clone 29E.2A3, Biolegend), anti-PD-L2 (clone MIH18, Biolegend), anti-CD276 (clone DCN.70, Biolegend), anti-CEACAM1 (clone ASL-32, Biolegend), anti-CD99 (clone HCD99, Biolegend), anti-Cadherin 11 (clone 667034, R and D systems), anti-MHC class I (clone W6-32, Serotec), anti-PCDHGC3 (cat no. ab89520, Abcam), anti-FAT1 (cat no. HPA023882, Sigma) and anti-ROR1 (clone 2H6, Abcam). Samples were acquired with a FACS Accuri flow cytometer and analyzed with FlowJo software (Tree Star).For intracellular flow cytometry of HCMV IE1, infected cells were trypsinised 24h after infection, fixed in 4% paraformaldehyde then permeabilised using Triton X-100. Fixed cells were incubated with BSA/human serum for 30 min, followed by anti-iE1 antibody (Thermo MA1-7596) for 30 min then anti-mouse AF647.ImmunoblottingGuanidine whole-cell lysates were precipitated using a ProteoExtract protein precipitation kit (Calbiochem). Proteins were re-dissolved in 2% SDS/Tris 200 mM pH8.5 with sonication. Protein concentration was measured by BCA (Pierce) then lysates were reduced with 100 mM DTT in loading buffer for 20 min at 65°C. Equal protein amounts were separated by SDS/PAGE using 4%--12% Bis-Tris polyacrylamide gels (Life Technologies), then transferred to PVDF membranes using the iBlot transfer system (Life Technologies). The following primary antibodies were used: anti-IFIT1 (clone 3G8, Lifespan), anti-IFIT3 (cat no. GTX112442, GeneTex), anti-MX1 (clone 2G12, GeneTex), anti-Calnexin (cat no. C142768, Lifespan), anti-MHC class I (clone HC-10, Abcam), anti-CD99 (cat no. ab108297, Abcam), anti-CLEC1A (cat no. AF1704, R and D systems), anti-FAT1 (cat no. HPA023882, Sigma), anti-PCDHGC3 (cat no. sc-134416, Santa Cruz), anti-IRF3 (clone FL-425, Santa Cruz), anti-NF-kB p50/105 (cat no. sc-7178, Santa Cruz), anti-p65/RELA (cat no. sc-109, Santa Cruz), anti-Pan-Akt (clone C67E7, Cell Signaling), anti-actin (cat no. A2066, Sigma). HRP-conjugated secondary antibodies were anti-rabbit (Cell Signaling), anti-mouse (Santa Cruz) or anti-goat (Santa Cruz). Reactive bands were detected by SuperSignal West Pico substrate (Thermo).NK Cell CD107a Mobilization AssaysNK degranulation assays were performed in a similar manner to that described previously ([@bib160; @bib30]). This protocol was approved by the Cardiff University School of Medicine Ethics Committee Ref. no: 10/20. Briefly, IFN-α-activated PBMC were incubated in triplicate (donors A, B) or duplicate (donor C) with target cells and anti-CD107a-FITC mAb (3 μl for 10^6^ PBMC, clone H4A3, BD Biosciences) for 5h in the presence of BD GolgiStop (BD Biosciences) added 30 min after the start of the incubation. PBMC were harvested and stained with conjugated antibodies against CD3 (cat. no. 737657, Beckman Coulter) and CD56 (cat. no. A07788, Beckman Coulter), and fixed in 2% PFA before analysis by flow cytometry (BD Biosciences Accuri C Flow). siRNA-mediated knockdown of target cells was performed as instructed by the manufacturer (Life Technologies) and was confirmed by immnoblot. siRNA was obtained from QIAGEN (FAT1: cat no. SI02664424; CLEC1A: cat no. SI03100419; control: cat no. 1027280), and Lipofectamine RNAiMAX from Life Technologies (cat no. 13778-075).Generation of HCMV-Specific T Cell Lines and T Cell CD107a Mobilization AssaysHCMV HLA-A2 restricted peptide VLEETSVML-specific T cell lines were generated by stimulating PBMC with irradiated (6000 rad) peptide-coated (100 μg/ml for 1 hr at 37°C) autologous fibroblasts in RPMI supplemented with heat-inactivated 10% fetal calf serum, 2% human AB serum (RPMI-AB) and 10 IU/ml recombinant IL-2 (rIL-2). Cultures were re-fed every 3-4 days with an equal volume of RPMI-AB containing 20 IU/ml rIL-2.CD107 T cell mobilization assays were performed similarly to NK cell mobilization assays. Briefly, autologous fibroblasts were infected with HCMV strain Merlin at an moi of 10 for 72h then coated with VLE peptide (10 μg/ml at 37°C for 1 hr) prior to addition of effectors at an E:T ratio of 10:1. Blocking antibody experiments (anti-CEACAM1, clone ASL-32, Biolegend) were carried out in quadruplicate at 5 μg/ml, either in cultures in excess, or with pre-treatment for 10 min at 37°C before 2 washes with RPMI-10. Anti-CD107a-FITC (BD Biosciences) or isotype control was added with effectors and incubated for 1 hr before addition of BD Golgistop (BD Biosciences). Cultures were then incubated for 4 hr before cell surface staining with anti-CD8-APC (Biolegend). Samples were fixed in 2% PFA before analysis by flow cytometry (BD Biosciences Accuri C Flow).
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![Temporal Plasma Membrane Profiling of HCMV-Infected Fibroblasts\
(A) Workflow of experiments PM1 and WCL1.\
(B) Hierarchical cluster analysis of all proteins quantified in experiment PM1 and annotated "plasma membrane," "cell surface," "extracellular," or "short GO" ([Figure S1](#figs1){ref-type="fig"}A).\
(C) All ABC transporters quantified. One-way ANOVA with multiple hypothesis correction: ^∗^p \< 0.005, ^∗∗^p \< 0.0001.\
(D) Quantitation of all HCMV proteins reported present at the surface of infected fibroblasts. gB, gH, gL, gO, and UL132 are virion envelope glycoproteins expressed late in infection. One-way ANOVA with multiple hypothesis correction: ^∗^p \< 0.005, ^∗∗^p \< 0.0001.\
(E) Principal component analysis of all quantified proteins from experiments PM1 and WCL1 confirmed that biological replicates were highly reproducible and suggested that the major source of variability within a given experiment was duration of infection.\
(F) Correlation between proteins quantified in experiments PM1 and PM2.\
See also [Figure S1](#figs1){ref-type="fig"} and [Table S1](#mmc2){ref-type="supplementary-material"}.](gr1){#fig1}

![Temporal WCL Analysis of HCMV-Infected Fibroblasts Demonstrates Exquisite Regulation of ISGs\
(A) Hierarchical cluster analysis of all proteins quantified in experiment WCL2, and enlargement of the top cluster A that included multiple IFN-induced antiviral proteins. Right panels, example temporal profiles. The y axis shows relative abundance of each protein. Red diamonds, 12 hr after infection with irradiated HCMV.\
(B) Immunoblots of HFFF infected with HCMV confirm proteomic profiles.\
(C) Interferon-induced proteins were more potently upregulated by productive infection than infection with irradiated HCMV. For each protein, signal:noise from the 12 hr irradiated virus or productive infection samples, and both mock samples was normalized to 1. The order of samples mock 1 and mock 2 was randomized into mock (a) and mock (b). The difference in normalized signal:noise was then calculated as indicated, and histograms were plotted. Where \<0.05% of proteins were upregulated by infection with irradiated virus, 2% of proteins were upregulated by infection with live virus. These included 69 viral proteins and 84 human proteins, of which 39% are known ISGs.\
See also [Figure S2](#figs2){ref-type="fig"} and [Table S3](#mmc4){ref-type="supplementary-material"}.](gr2){#fig2}

![Modulation of Intracellular Signaling Pathways during HCMV Infection\
(A) Quantitation of interferon induction and response pathways. The temporal profile of each protein is shown over 96 hr of infection, and colored red (downregulation), blue (unchanged), or green (upregulation). Data were derived from experiment WCL2 apart from IFNAR1 and IFNAR2, from PM2. Expression of certain ISGs is known to occur in the absence of IFN, in an IRF3-dependent manner. PRR, pattern recognition receptors.\
(B) Average temporal profiles from 3-class k-means clustering of proteins quantified in experiments WCL2 and PM2. The three classes divided proteins into downregulated (red), unchanged (blue), or upregulated (green).\
(C) Enrichment of KEGG pathways within each class was determined using DAVID software, against a background of all quantified proteins. Benjamini-Hochberg adjusted p values are shown for each indicated bar (^∗^p \< 0.00001, ^∗∗^p \< 0.0001, ^∗∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.05). Individual pathways are shown in [Figures S3](#figs3){ref-type="fig"}A--S3C, and pathway members are shown in [Table S4](#mmc5){ref-type="supplementary-material"}.](gr3){#fig3}

![Temporal Changes in Known and Putative Cell-Surface Immunomodulators\
(A) Temporal profiles of known NK ligands whose modulation by HCMV had not previously been recognized.\
(B) Temporal profiles of T cell ligands not previously known to be modulated during infection.\
(C) Temporal profiles of all quantified protocadherins.\
(D) Validation of the temporal profile of PDCHγC3 by flow cytometry.\
Red diamonds, 12 hr after infection with irradiated HCMV. See also [Figure S4](#figs4){ref-type="fig"}, [Table S5](#mmc6){ref-type="supplementary-material"}, and [Data S1](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Definition of Temporal Classes of HCMV Gene Expression\
(A) The k-means method was used to cluster all quantified HCMV proteins (experiment WCL2) into four or five classes. Shown are the average temporal profiles of each class. With four classes, proteins grouped into classes similar to the classical IE/E/E-L/L cascades. With five classes, a distinct temporal profile appeared (blue).\
(B) Number of temporal classes of HCMV gene expression. The summed distance of each protein from its cluster centroid was calculated for one to 14 classes and plotted. The point of inflexion fell between five and seven classes.\
(C) Top: temporal profiles of proteins in each k-means class (experiment WCL2) were subjected to hierarchical clustering by Euclidian distance. Both UL112 and isoform p50 of UL112 (UL112-2) were quantified. UL122 was excluded from clustering due to uncertainty in peptide assignment. Bottom: experiment WCL3. Viral protein profiles were further assessed in the presence or absence of the viral DNA replication inhibitor PFA. Proteins are displayed in the same order as the clusters defined in the upper panels.\
(D) Temporal profiles of typical proteins from each cluster (upper panel), and the corresponding profiles in the presence or absence of PFA (lower panel).\
See also [Figure S5](#figs5){ref-type="fig"}, [Table S6](#mmc7){ref-type="supplementary-material"}, and [Data S1](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

![HCMV Proteins Quantified at the Surface of Infected Fibroblasts\
(A) Histogram of peptide ratios for all GO-annotated proteins quantified in experiments PM1 or PM2. "PM only," not detected in experiments WCL1 or WCL2. "PM annotation": "plasma membrane", "cell surface," "extracellular," or "short GO."\
(B) Temporal profiles of all high-confidence PM proteins ([Table S6](#mmc7){ref-type="supplementary-material"}). Virion envelope glycoproteins were generally detected significantly earlier in whole-cell lysates than in plasma membrane samples. Arrows, quantitation of fusion or binding of the virion envelope and the plasma membrane.\
See also [Figure S6](#figs6){ref-type="fig"} and [Table S7](#mmc8){ref-type="supplementary-material"}.](gr6){#fig6}

![QTV Provides Mechanistic Insights into Downregulated Cell-Surface Targets\
(A) Proteins that are known to be sequestered within the cell accumulated in WCL samples during infection.\
(B) Proteins targeted for lysosomal or proteasomal degradation declined during infection.\
Red diamonds, 12 hr after infection with irradiated HCMV. See also [Figures S7](#figs7){ref-type="fig"}A and S7B.](gr7){#fig7}

![Temporal Plasma Membrane Profiling of HCMV-Infected Fibroblasts, Related to [Figure 1](#fig1){ref-type="fig"}\
(A) Gene ontology annotation of proteins quantified in experiment PM1. Peptides were analyzed by mass spectrometry either unfractionated, or after division into 6 fractions using offline strong cation exchange. '\'Short GO" refers to a subset of proteins annotated by GO as integral to the membrane, but with no subcellular assignment and a short 4- or 5-part GO cellular compartment term ([@bib47]).\
(B) Quantitation of all cell surface proteins that exhibit previously reported changes during productive HCMV infection in HFFFs. Protein temporal profiles correlated well between repeat time courses PM1 (upper panels) and PM2 (lower panels). MICB and ULBP1 were not quantified in experiment PM1. Because of sequence similarities it was not possible to distinguish individual isoforms of HLA-B, and these data are not included. Red diamonds -- irradiated HCMV infection at 12h. One-way ANOVA with multiple hypothesis correction: ^∗^p \< 0.005, ^∗∗^p \< 0.0001. Red diamonds -- 12h after infection with irradiated HCMV.\
(C) Hierarchical clustering of proteins quantified in whole-cell lysate experiment WCL1. Fold change was limited to a maximum of 50.\
(D) Workflow of 10-plex TMT experiments. ^∗^12h after infection with irradiated HCMV.\
(E) Hierarchical clustering of proteins quantified in plasma membrane experiment PM2. Fold change was limited to a maximum of 50.\
(F) Correlation between proteins quantified in both experiments WCL1 and WCL2.](figs1){#figs1}

![Modulation of Viral Restriction Factors during HCMV Infection, Related to [Figure 2](#fig2){ref-type="fig"}\
(A) Sp100 is known to be targeted for degradation by HCMV IE1 ([@bib18]). Modulation of SAMHD1, ZAP and SLFN11 had not previously been recognized.\
(B) Quantitation of 21 TRIMs during infection. Results are shown from experiments WCL2 (top sets of panels) and WCL1 (bottom sets of panels). 8 TRIMs were not quantified in experiment WCL1. One-way ANOVA with multiple hypothesis correction (experiment WCL1): ^∗^p \< 0.005.\
Red diamonds -- 12h after infection with irradiated HCMV.](figs2){#figs2}

![QTV Provides Insights into Modulated Signaling Pathways, Related to [Figure 3](#fig3){ref-type="fig"}\
(A) The Toll-like receptor signaling pathway and its modulation during HCMV infection, based on the KEGG pathway ([@bib118]). Proteins (ovals) are shaded to correspond to their clusters ([Figure 3](#fig3){ref-type="fig"}B): red (downregulated), blue (unchanged), green (upregulated), gray (not quantified). Edges (from KEGG) are shaded green with arrows, to indicate that protein A activates protein B and pink to indicate that protein A inhibits protein B. A single gray/black edge with arrow indicates that protein A affects protein B - not labeled as activation or inhibition. A paired gray/black arrow between proteins A and B: protein A and B bind to or are associated with one another. Phosphorylation events are labeled with p+.\
(B) Immunoblots of HFFF infected with HCMV confirm proteomic profiles for three TLR-pathway members.\
(C) The gap junction pathway, shaded as for [Figure S3](#figs3){ref-type="fig"}A.\
(D) Modulation of cell surface wnt receptors. 11/13 quantified canonical and non-canonical wnt receptors were downregulated. The WCL2 β-catenin profile demonstrated a modest decline over time. Red diamonds -- 12h after infection with irradiated HCMV.](figs3){#figs3}

![Validation of Temporal Profiles by Flow Cytometry and Immunoblot and Investigation of Novel Immune Ligands, Related to [Figure 4](#fig4){ref-type="fig"}\
(A) PM and WCL profiles of MHC-I (HLA-A11) and CD99, validated by flow cytometry and immunoblot. ≥ 95% of HFFF were routinely infected by HCMV, assessed by flow cytometry for cell surface MHC-I.\
(B) Representative intracellular flow cytometry of 24h-infected HFFF with anti-IE1 confirms \> 95% infection efficiency.\
(C) Flow cytometry of HFFF infected with HCMV confirms proteomic profiles for five additional cell surface proteins.\
(D and E) NK degranulation assays suggest that CLEC1A and FAT1 are novel activating NK ligands. Top panels -- validation of temporal PM and WCL profiles by flow cytometry and immunoblot. CLEC1A was not quantified in any WCL QTV experiments but accumulated by immunoblot of whole-cell lysates, while depleting from the PM. Bottom panels -- target cells underwent siRNA knockdown of CLEC1A (D) or FAT1 (E) and were then incubated with stimulated polyclonal NK cells from each of three donors. Degranulation of NK cells in response to both CLEC1A and FAT1 knockdown targets was significantly reduced compared to control. Error bars: +/− SEM (donors A, B), +/− range (donor C). ^∗^ two-tailed p-value \< 0.05, ^∗∗^ two-tailed p-value \< 0.005. Cell surface MHC-I was unaffected by siRNA (right bottom panels, staining with W6-32 antibody or control Ig).\
(F) CD8+ T cell degranulation assay suggests that CEACAM1 is a novel inhibitory ligand for CMV-specific cytotoxic T cells. Top panel -- validation of temporal PM profile by flow cytometry. Bottom panels (left) -- flow cytometry of a CD8+ T cell line specific to the HCMV HLA-A2 restricted IE1 peptide VLEETSVML confirmed CEACAM1 surface expression. (right) HCMV peptide-specific CD8+ effector cells were incubated with autologous fibroblasts that had been infected with HCMV for 72h then pulsed with peptide or left unpulsed. Effectors and targets were treated with control Ig or anti-CEACAM1. HCMV-specific T cell degranulation was significantly increased with CEACAM1 block. Error bars ± SEM. ^∗^ two-tailed p-value \< 0.0001.\
y-axes of QTV plots represent relative abundance, and y-axes of flow cytometry plots represent % of max.](figs4){#figs4}

![Further Details of Specific HCMV Proteins and Protein/mRNA Profiles, Related to [Figure 5](#fig5){ref-type="fig"}\
(A) All peptides quantified from the major immediate early region spanning UL122 (IE2) -- UL123 (IE1). Peptides from exon 4 are unique to UL123. Peptides from exons 1-3 were assigned to IE1 protein by our data processing software, according to the principles of parsimony. Expression of ten exon 5 peptides corresponding to ORFL265C.iORF1 (lower panel) peaked late at 96h, in comparison to a single peptide N-terminal to this region, which is likely to have derived from UL122 itself. The lower panel shows a map of internal ORFs detected by exon 5 ribosomal footprinting ([@bib36]). ^∗^ in peptide sequence: methionine oxidation.\
(B) Relationship between four novel ORFs and their canonical HCMV counterparts, with temporal profiles. Each of the novel ORFs were quantified based only on unique peptides that could only have originated from that ORF. Peptides that could either have originated from the canonical protein or the novel ORF were assigned to the canonical protein.\
(C) k-means clusters of (i) all quantified canonical HCMV proteins with 9 novel ORFs (experiment WCL2, also shown in [Figure 5](#fig5){ref-type="fig"}A) and (ii) all quantified canonical HCMV mRNAs and the same 9 novel ORFs ([@bib36]). 5 clusters were selected in each case. The plots shown represent the average temporal profile for each cluster. As there were no intermediate mRNA time points between 5 and 24 hr, or between 24 and 72 hr, there was insufficient information to make an accurate comparison between the central three mRNA clusters and our Tp2, Tp3, or Tp4 class proteins. We therefore used mRNA data to define 3 classes: Tr1, Tr2-4, and Tr5. See [Table S6](#mmc7){ref-type="supplementary-material"}C for details of the class of each protein.\
(D) Comparison between temporal protein profiles (this study) and mRNA expression profiles ([@bib36]), grouped according to protein class. The 134 viral genes quantified in both studies are shown. For each protein or transcript, expression was normalized to the maximum across the measured time points. There was extremely good correspondence between protein and mRNA temporal profiles for Tp1 and Tp5 protein classes. Correspondence was less good for Tp2-4 protein classes as there were insufficient intermediate RNA time points to determine when maximal mRNA expression occurred.\
Red diamonds -- 12h after infection with irradiated HCMV.](figs5){#figs5}

![Temporal Profiles of "High-Confidence" Viral PM Proteins that Were Quantified in Experiment PM1, Related to [Figure 6](#fig6){ref-type="fig"}\
Known virion envelope glycoproteins (starred) were generally detected significantly earlier in whole-cell lysates than in plasma membrane samples ([Figure 6](#fig6){ref-type="fig"}). Values shown are averages of two biological replicates, +/− range. See also [Table S7](#mmc8){ref-type="supplementary-material"}.](figs6){#figs6}

![QTV Informs about Mechanism of Modulation of Cell-Surface Targets, Related to [Figure 7](#fig7){ref-type="fig"}\
(A) Further examples of mechanistic insights into downregulated cell surface immunomodulators. TRAILR2 is retained in the ER by UL141 ([@bib178]). MICA is retained in the *cis*-Golgi by UL142 ([@bib58]). UL142 was only quantified at the plasma membrane ([Figure S5](#figs5){ref-type="fig"}A) and is not shown here.\
(B) Examples of mechanistic insights into upregulated cell surface ligands, or receptors with complex patterns of expression. Signal peptide from HCMV UL40 acts to promote cell surface expression of HLA-E ([@bib161]). The WCL pattern of expression of UL40 was extremely similar to cell surface HLA-E, and is shown overlying both PM and WCL data to illustrate this. TNFR1 cell surface expression is upregulated by UL138, which has a dominant effect. Other virally encoded functions may downregulate TNFR1 expression ([@bib142]). The WCL pattern of expression of UL138 is shown overlying both PM and WCL data.\
Red diamonds -- 12h after infection with irradiated HCMV.](figs7){#figs7}
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